Diagnosis of insulin resistance in hypertensive patients by the metabolic syndrome: AHA vs. IDF definitions

International Journal of Clinical Practice

Volumn 62, Issue 9, 2008, Pages 1441-1446

  Hwu, C M ^a,b   Hsiung, C A ^c   Wu, K D ^d   Lee, W J ^e   Shih, K C ^f   Grove, J ^g,h   Chen, Y D I ⁱ   Rodriguez, B L ^h   Curb, J D ^h  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^f TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^g UNIVERSITY OF HAWAII   (United States)

^h PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

ⁱ CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; GLUCOSE; INSULIN; ISOPHANE INSULIN; SOMATOSAN; SOMATOSTATIN; TAIYU; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE;

EID: 49349089595     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01818.x     Document Type: Article

References (24)

1. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991 14: 173 94.
2. Reaven GM. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab 2003 88: 2399 403.
3. Hwu CM. Measurements of insulin resistance in hypertension: where are we now? J Hum Hypertens 2007 21: 693 6.
4. Hwu CM, Hsiao CF, Grove J et al. Surrogate estimates of insulin sensitivity in subjects with hypertension. J Hum Hypertens 2007 21: 246 52.
5. Karter AJ, Mayer-Davis EJ, Selby JV et al. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin resistance and Atherosclerosis Study. Diabetes 1996 45: 1547 55.
6. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003 139: 802 9.
7. Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006 47: 1093 100.
8. Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES. Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004 53: 1195 200.
9. Liao Y, Kwon S, Shaughnessy S et al. Critical evaluation of Adult Treatment Panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care 2004 27: 978 83.
10. Sierra-Johnson J, Johnson BD, Allison TG, Bailey KB, Schwartz GL, Turner ST. Correspondence between the Adult Treatment Panel III criteria for metabolic syndrome and insulin resistance. Diabetes Care 2006 29: 668 72.
11. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005 112: 2735 52.
12. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006 23: 469 80.
13. Lin MW, Hwu CM, Huang YH et al. Directly measured insulin resistance and the assessment of clustered cardiovascular risks in hypertension. Am J Hypertens 2006 19: 1118 24.
14. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007 30: 8 13.
15. Lind L, Berne C, Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens 1995 13: 1457 62.
16. Guerrero-Romero F, Rodríguez-Morán M. Lowering criterion for normal fasting glucose: impact on the detection of impaired glucose tolerance and metabolic syndrome. Arch Med Res 2006 37: 140 4.
17. Pei D, Kuo SW, Wu DA et al. The relationships between insulin resistance and components of metabolic syndrome in Taiwanese Asians. Int J Clin Pract 2005 59: 1408 16.
18. Haffner SM, D'Agostino R Jr, Mykkänen L et al. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care 1999 22: 562 8.
19. Levy J, Atkinson AB, Bell PM, McCance DR, Hadden DR. Beta-cell deterioration determines the onset and the rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet Med 1998 15: 290 6.
20. García-Puig J, Ruilope LM, Luque M et al. Glucose metabolism in patients with essential hypertension. Am J Med 2006 119: 318 26.
21. Wu KD, Hsiao CF, Ho LT et al. Clustering and heritability of insulin resistance in Chinese and Japanese hypertensive families: a Stanford-Asian Pacific Program in Hypertension and Insulin Resistance Sibling Study. Hypertens Res 2002 25: 529 36.
22. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 2005 54: 333 9.
23. Bigazzi R, Bianchi S, Buoncristiani E, Campese VM. Increased cardiovascular events in hypertensive patients with insulin resistance: a 13-year follow-up. Nutr Metab Cardiovasc Dis 2008 18: 314 9.
24. Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB Sr, Wilson PWF. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 2007 30: 1219 25.